Dystonia: A clinical approach

Acta Neurologica Taiwanica

Volumn 17, Issue 4, 2008, Pages 219-227

  Edwards, Mark J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Diagnosis; Dystonia; Investigation; Primary; Treatment

Indexed keywords

BACLOFEN; BINDING PROTEIN; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; EPSILON SARCOGLYCAN; GABAPENTIN; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; PARKIN; PROTEIN DYT1; TETRABENAZINE; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; BLOOD ANALYSIS; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN RADIOGRAPHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTONIA; DYSTONIA PLUS SYNDROME; ELECTRORETINOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; LIVER BIOPSY; MOTOR DYSFUNCTION; MUTATIONAL ANALYSIS; MYOCLONUS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; POPULATION GENETICS; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SLIT LAMP; SYMPTOM; TARDIVE DYSKINESIA; TREMOR; UNSPECIFIED SIDE EFFECT; URINALYSIS;

AGE OF ONSET; ATAXIA; DIAGNOSIS, DIFFERENTIAL; DYSTONIC DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; SYNDROME; TREMOR;

EID: 58149295424     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Bhatia KP, Bhatt MH, Marsden CD. The causalgia-dystonia syndrome. Brain 1993;116:843-51.
2. Bhatia KP. Familial (idiopathic) paroxysmal dyskinesias: an update. Semin Neurol 2001;21:69-74.
3. Edwards MJ, Quinn NP, Bhatia KP. Parkinson's Disease and Other Movement Disorders. Oxford: Oxford University Press, 2008.
4. Espay AJ, Morgante F, Purzner J, et al. Cortical and spinal abnormalities in psychogenic dystonia. Ann Neurol 2006; 59:825-34.
5. Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol 1988;50:431-55.
6. Mink JW. Paroxysmal dyskinesias. Curr Opin Pediatr 2007;19:652-6.
7. Schrag A, Trimble M, Quinn N, et al. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain 2004; 127:2360-72.
8. Schrag A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol 2005;18:399-404.
9. Ozelius LJ, Hewett JW, Page CE, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997;17:40-8.
10. Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000;54:1746-52.
11. Edwards M, Wood N, Bhatia K. Unusual phenotypes in DYT1 dystonia: a report of five cases and a review of the literature. Mov Disord 2003;18:706-11.
12. Edwards MJ, Huang YZ, Mir P, et al. Abnormalities in motor cortical plasticity differentiate manifesting and non-manifesting DYT1 carriers. Mov Disord 2006;21:2181-6.
13. Bressman SB, de Leon D, Kramer PL, et al. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol 1994;36:771-7.
14. Coubes P, Cif L, El Fertit H, et al. Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results. J Neurosurg 2004;101: 189-94.
15. Almasy L, Bressman SB, Raymond D, et al. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol 1997;42:670-3.
16. Bentivoglio AR, Ialongo T, Contarino MF, et al. Phenotypic characterization of DYT13 primary torsion dystonia. Mov Disord 2004;19:200-6.
17. Leube B, Hendgen T, Kessler KR, et al. Evidence for DYT7 being a common cause of cervical dystonia (torticollis) in Central Europe. Am J Med Genet 1997;74:529-32.
18. Ozelius LJ. Update on the genetics of primary torsion dystonia loci DYT6, DYT7, and DYT13 and the dystonia-plus locus DYT12. Adv Neurol 2004;94:109-12.
19. Valente EM, Bentivoglio AR, Cassetta E, et al. Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1p36 in an Italian family with cranial-cervical or upper limb onset. Neurol Sci 2001;22: 95-6.
20. Koukouni V, Martino D, Arabia G, et al. The entity of young onset primary cervical dystonia. Mov Disord 2007; 22:843-7.
21. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003;54:S32-S45.
22. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-42.
23. Bandmann O, Marsden CD, Wood NW. Atypical presentations of dopa-responsive dystonia. Adv Neurol 1998;78: 283-90.
24. Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991;41:174-81.
25. Bandmann O, Goertz M, Zschocke J, et al. The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 2003;60:700-2.
26. Abeling NG, Duran M, Bakker HD, et al. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia. Mol Genet Metab 2006;89:116-20.
27. Bartholome K, Ludecke B. Mutations in the tyrosine hydroxylase gene cause various forms of L-dopa-responsive dystonia. Adv Pharmacol 1998;42:48-9.
28. Quinn NP. Essential myoclonus and myoclonic dystonia. Mov Disord 1996;11:119-24.
29. Quinn NP, Rothwell JC, Thompson PD, et al. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv Neurol 1988;50:391-401.
30. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001;29:66-9.
31. Valente EM, Edwards MJ, Mir P, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 2005; 64:737-9.
32. Asmus F, Zimprich A, Tezenas Du Montecl S, et al. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol 2002;52:489-92.
33. Grabowski M, Zimprich A, Lorenz-Depiereux B, et al. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonusdystonia syndrome, is maternally imprinted. Eur J Hum Genet 2003;11:138-44.
34. Müller B, Hedrich K, Kock N, et al. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 2002;71:1303-11.
35. Brashear A, Dobyns WB, de Carvalho AP, et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain 2007;130:828-35.
36. de Carvalho Aquiar P, Sweadner KJ, Penniston JT, et al. Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004;43:169-75.
37. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994;117:859-76.
38. Kiriakakis V, Bhatia KP, Quinn NP, et al. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 1998;121:2053-66.
39. Karp BI, Goldstein SR, Chen R, et al. An open trial of clozapine for dystonia. Mov Disord 1999;14:652-7.
40. Adityanjee, Estrera AB. Successful treatment of tardive dystonia with clozapine. Biol Psychiatry 1996;39:1064-5.
41. van Harten PN, Kampuis DJ, Matroos GE. Use of clozapine in tardive dystonia. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:263-74.
42. Trugman JM, Leadbetter R, Zalis ME, et al. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Mov Disord 1994;9:441-6.
43. Franzini A, Marras C, Ferroli P, et al. Long-term high-frequency bilateral pallidal stimulation for neuroleptic-induced tardive dystonia. Report of two cases. J Neurosurg 2005;102:721-5.
44. Cohen OS, Hassin-Baer S, Spiegelmann R. Deep brain stimulation of the internal globus pallidus for refractory tardive dystonia. Parkinsonism Relat Disord 2007;13:541-4.
45. Zhang JG, Zhang K, Wang ZC, et al. Deep brain stimulation in the treatment of secondary dystonia. Chin Med J (Engl) 2006;119:2069-74.
46. Trottenberg T, Volkmann J, Deuschl G, et al. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology 2005;64:344-6.
47. Jankovic J. Dystonia: medical therapy and botulinum toxin. Adv Neurol 2004;94:275-86.
48. Comella CL, Thompson PD. Treatment of cervical dystonia with botulinum toxins. Eur J Neurol 2006; 13:16-20.
49. Bereznai B, Steude U, Seelos K, et al. Chronic high-frequency globus pallidus internus stimulation in different types of dystonia: a clinical, video, and MRI report of six patients presenting with segmental, cervical, and generalized dystonia. Mov Disord 2002; 17:138-44.
50. Eltahawy HA, Saint-Cyr J, Poon YY, et al. Pallidal deep brain stimulation in cervical dystonia: clinical outcome in four cases. Can J Neurol Sci 2004;31:328-32.
51. Foote KD, Sanchez JC, Okun MS. Staged deep brain stimulation for refractory craniofacial dystonia with blepharospasm: case report and physiology. Neurosurgery 2005;56:E415.
52. Islekel S, Zileli M, Zileli B. Unilateral pallidal stimulation in cervical dystonia. Stereotact Funct Neurosurg 1999; 72:248-52.
53. Cif L, Valente EM, Hemm S, et al. Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord 2004; 19:724-7.
54. Cif L, El Fertit H, Vayssiere N, et al. Treatment of dystonic syndromes by chronic electrical stimulation of the internal globus pallidus. J Neurosurg Sci 2003;47:52-5.